Niemann–Pick type C disease as proof‐of‐concept for intelligent biomarker panel selection in neurometabolic disorders

AIM: Using Niemann–Pick type C disease (NPC) as a paradigm, we aimed to improve biomarker discovery in patients with neurometabolic disorders. METHOD: Using a multiplexed liquid chromatography tandem mass spectrometry dried bloodspot assay, we developed a selective intelligent biomarker panel to mon...

Descripción completa

Detalles Bibliográficos
Autores principales: Papandreou, Apostolos, Doykov, Ivan, Spiewak, Justyna, Komarov, Nikita, Habermann, Stephanie, Kurian, Manju A., Mills, Philippa B., Mills, Kevin, Gissen, Paul, Heywood, Wendy E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796541/
https://www.ncbi.nlm.nih.gov/pubmed/35833379
http://dx.doi.org/10.1111/dmcn.15334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796541/
https://www.ncbi.nlm.nih.gov/pubmed/35833379
http://dx.doi.org/10.1111/dmcn.15334

Ejemplares similares